RTOG 0924: Androgen Deprivation Therapy and High Dose Radiotherapy with or without Whole-pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial

June 29, 2018
https://clinicaltrials.gov/ct2/show/NCT01368588
Cancer - Genitourinary/ Prostate
Principal Investigator: Eleanor M Walker, MD
Cancer, Prostate, Prostate Cancer, Intermediate, High Risk, Favorable, Unfavorable, Phase 3, Phase III, RTOG, 
Accepting Participants